The North America Cosmetic Surgery And Procedure Market would witness market growth of 9.0% CAGR during the forecast period (2021-2027).
Cosmetic facial plastic surgery processes appear to function in the marketplace as luxury products, with just an upward-sloping demand curve. It is more traditional goods, where demand typically reduces as prices rise. Economic methods appear to be capable of assessing cosmetic procedure trends. However, such techniques are formed on appropriate economic theory.
Excess skin and fat are excluded from the abdomen, and the underlying abdomen muscle fibers are stiffened. The navel is usually needed to be relocated. Incisions are usually made along the 'bikini line' to minimize scarring visibility. This method is conducted under anesthesia. Numbness and inconvenient cramping are common symptoms of surgery that can last for months. Infection and the creation of fluid pockets are two complications.
Facial fillers are injected temporarily to soften wrinkles. Infusion of facial padding is usually performed as an outpatient surgery under local anesthetics. The procedure can take over an hour. The implications could be long-term. Moreover, achieving the desired results usually necessitates more than one meeting of infusions, along with overstocking the location to recompense again for the body's absorption of nutrients of the fat.
As per the American Society of Plastic Surgeons, 13,281,235 cosmetic nonsurgical processes were performed in the United States in 2020, with botulinum toxin procedures accounting for 4,401,536 along with Non-invasive body fat removal was among the top 5 non-invasive operations in the United States in 2020, according to the Aesthetic Society (US), with 140,314 procedures completed.
In the United States, there is much more rivalry, with several companies launching many products, for example, Allergan got approval from the US FDA in July 2021 to extend the label of BOTOX that included eight new muscles for treating upper limb stiffness in adults. Additionally, elbow and forearm muscles are one of the new muscles to be treated.
The usage of botulinum toxins in aesthetic medicine has increased. The cosmetic reasons approved by the US FDA for Botox injections are frowning wrinkles, crow's feet, and horizontal forehead lines. They offer accurate results with low side effects and are related to higher patient satisfaction as the substance's use expands. As a result, the segment is predicted to grow rapidly over the world.
The US market dominated the North America Cosmetic Surgery And Procedure Market by Country in 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $27,013.9 million by 2027. The Canada market is anticipated to grow at a CAGR of 11.5% during (2021 - 2027). Additionally, The Mexico market would display a CAGR of 10.5% during (2021 - 2027).
Based on Procedure Type, the market is segmented into Non-invasive, and Invasive. Based on Non-invasive Type, the market is segmented into Botox Injections, Laser Hair Removal, Soft Tissue Fillers, Chemical Peel, Microdermabrasion, and Others. Based on Invasive Type, the market is segmented into Breast Augmentation, Liposuction, Nose Reshaping, Tummy Tuck, Eyelid Surgery, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Cosmetic Surgery and Procedure Market is Estimated to reach $107.2 Billion by 2027, at a CAGR of 9.8%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Evolus, Inc., Revance Therapeutics, Inc., Cynosure, LLC, Alma Lasers Ltd., Candela Medical Corporation, Bausch Health Companies, Inc., Lumenis Ltd., Galderma S.A., and AbbVie, Inc.
By Procedure Type
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 